4DMedical (ASX:4DX) secured a commercial contract with Utah-based Intermountain Health to implement its pulmonary hypertension analysis product, according to a Monday filing with the Australian bourse.
The pulmonary hypertension analysis product is an artificial-intelligence-based algorithm designed for acute care settings to aid response teams in assessing pulmonary hypertension due to pulmonary embolism, the filing said.
The contract was secured through Microsoft-owned Nuance Communications as part of the company's strategic distribution partnership, according to the filing.
4DMedical shares were up 5% in morning trade on Monday.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。